Variations in organism-specific severe sepsis mortality in the United States: 1999-2008.
about
Early goal-directed therapy in severe sepsis and septic shock: insights and comparisons to ProCESS, ProMISe, and ARISEThe intestinal microbiome and surgical disease.Bacteriophages from ExPEC Reservoirs Kill Pandemic Multidrug-Resistant Strains of Clonal Group ST131 in Animal Models of BacteremiaCombined administration of a sedative dose sevoflurane and 60% oxygen reduces inflammatory responses to sepsis in animals and in human PMBCs.Levosimendan attenuates multiple organ injury and improves survival in peritonitis-induced septic shock: studies in a rat model.Evolving trends in the epidemiology, resource utilization, and outcomes of pregnancy-associated severe sepsis: a population-based cohort study.Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010.Murine model of chemotherapy-induced extraintestinal pathogenic Escherichia coli translocationHigh Mortality from Blood Stream Infection in Addis Ababa, Ethiopia, Is Due to Antimicrobial Resistance.Synergistic Action of Staphylococcus aureus α-Toxin on Platelets and Myeloid Lineage Cells Contributes to Lethal SepsisThe tyrosine kinase inhibitor imatinib prevents lung injury and death after intravenous LPS in mice.Epidemiology and antimicrobial susceptibilities of wound isolates of obligate anaerobes from combat casualtiesSepsis Patients with First and Second-Hit Infections Show Different Outcomes Depending on the Causative Organism.Activation of Bacteroides fragilis toxin by a novel bacterial protease contributes to anaerobic sepsis in mice.Micheliolide provides protection of mice against Staphylococcus aureus and MRSA infection by down-regulating inflammatory response.Epidemiology and Microbiology of Sepsis Syndromes in a University-Affiliated Urban Teaching Hospital and Level-1 Trauma and Burn Center.The current treatment landscape: candidiasis.Results from a 13-Year Prospective Cohort Study Show Increased Mortality Associated with Bloodstream Infections Caused by Pseudomonas aeruginosa Compared to Other Bacteria.Bloodstream Infections: The peak of the iceberg.Host derived biomarkers of inflammation, apoptosis, and endothelial activation are associated with clinical outcomes in patients with bacteremia and sepsis regardless of microbial etiology.Low-dose corticosteroid treatment and mortality in refractory abdominal septic shock after emergency laparotomy.Butyricimonas virosa: the first clinical case of bacteraemia.Significance of hydrogen sulfide in sepsis-induced myocardial injury in rats.Antibacterial and immunomodulatory activities of insect defensins-DLP2 and DLP4 against multidrug-resistant Staphylococcus aureus.Use of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation after intestinal perforation.Risk factors and outcomes of endocarditis due to non-HACEK Gram-negative bacilli: data from the prospective multicenter SEI cohort.Group 2 innate lymphoid cells protect lung endothelial cells from pyroptosis in sepsis.ICU mortality following ICU-acquired primary bloodstream infections according to the type of pathogen: A prospective cohort study in 937 Germany ICUs (2006-2015).
P2860
Q26745899-1F2218F6-055C-4F13-B2A0-4E4B6CA739DDQ30248605-D394AEC1-04D4-4AA0-8960-A311E7CB7D6BQ30401003-30810563-4BF8-413C-9A63-C7E42BE0A1F7Q33850362-66FDE4D0-9378-4611-A629-F377B4016916Q34761833-2B07B96A-E7F8-4E99-AF09-EFA3309EEEC8Q35387173-DE5BBCC9-C981-4C10-9E83-D1DFE628BAAEQ35602372-67267B6D-D9B1-4E1F-9C31-39D7BDD4A36CQ35833848-763BD4E2-83B2-4EA3-8F28-8899A84C2EE4Q35869536-6EFFF530-E262-4F2E-80C0-8D0DF882C3E7Q36274821-E4552FDC-2C2F-4309-BFF1-97C1EC4DA3F6Q36357495-E76E5F57-5792-4408-9365-2E8620ECAABCQ36473974-EF3CD35F-2C7D-4332-9B34-69CD8AE52156Q36620689-37FA6186-5C5C-45CB-9D08-900906ABD99AQ36880091-B9F1EAFF-7905-4F2F-8ACC-CD5E454F5C61Q37625743-09AD138A-8F74-4210-B410-15BB20230318Q38541206-F44D0FA6-9F3D-4AEB-A080-ABF58008C10CQ39018200-54063162-6A3F-4CB3-86E0-6FF467C2A69AQ40266263-86D80F4B-593E-4508-9C35-435742F5AA2AQ40786443-9B5EA358-C2DE-442C-A814-C5C3C9E7A74CQ40815332-FDBD76E8-AFE5-480C-A60F-DF07C4AC81C3Q41171549-C4939750-97B9-4909-B429-01992445FBF5Q41364762-1AE6E0A7-836D-4EC6-A149-593F1C3A714DQ41672650-6C66516E-851D-4DEB-B3A1-10D1EED18C75Q42362336-8E60D42B-AFE5-4F21-82A4-73ADC75B1F01Q43163829-4EAB1D80-4EE8-4350-91EA-3301CCFCBA71Q49598764-38AE2980-98CE-47EC-9BB2-F50C72731F23Q52671128-D9230E35-4B8D-4239-AFC5-24A41BB5DEBDQ52808222-EF646326-4B45-4D14-86F8-348053B66A32
P2860
Variations in organism-specific severe sepsis mortality in the United States: 1999-2008.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Variations in organism-specific severe sepsis mortality in the United States: 1999-2008.
@en
Variations in organism-specific severe sepsis mortality in the United States: 1999-2008.
@nl
type
label
Variations in organism-specific severe sepsis mortality in the United States: 1999-2008.
@en
Variations in organism-specific severe sepsis mortality in the United States: 1999-2008.
@nl
prefLabel
Variations in organism-specific severe sepsis mortality in the United States: 1999-2008.
@en
Variations in organism-specific severe sepsis mortality in the United States: 1999-2008.
@nl
P2093
P1476
Variations in organism-specific severe sepsis mortality in the United States: 1999-2008.
@en
P2093
Amy Bellinghausen Stewart
Chizobam Ani
H Bryant Nguyen
Siavash Farshidpanah
P356
10.1097/CCM.0000000000000555
P407
P577
2015-01-01T00:00:00Z